Summary:
Arizona Research Center is conducting a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Episodic Migraine
Qualified Participants Must:
• Be between 18 and 65 years of age
•
Have onset of migraines prior to age 50
•
Currently be experiencing chronic migraines for at least the past 3 months